PDZK1IP1 and neoplasm: Enhanced inflammation surrounding target tissues could be a tumor promotion mechanism led by MAP17 deregulation controlling the development of hematopoietic cells that regulate inflammation, and mediate the responses of target cells to inflammatory cytokines.